With an increase in market competition, laboratory automation has become an indispensable tool for laboratories to keep up with rising work pressure. However, high costs associated with complete laboratory automation and space constraints can act as major limitations for a lot of small and medium scale laboratories in adopting these systems. Therefore, automation vendors are developing alternate hardware configurations known as 'modular automation’ that can fit these smaller laboratories. Modular automation comprises integrated analyzers, consolidated analyzers, modular workcells, and pre- and post-analytical automation. These modular automated systems are complimented with the latest modern software.
The life sciences sector comprises the pharmaceutical, biotech, and health care segments. Revenues in the sector are increasing globally. This has been partly attributed to growth in emerging markets and the positive demographics in those markets and the leading edge of life sciences companies resulting in blockbuster innovations. These innovations are facilitated by meticulous and vigorous R&D efforts by global players and academia in all the aforementioned segments. R&D requires high throughput analysis technology and work stations. Hence, it is driving demand for laboratory automation, including modular laboratory automation. Increase in income levels in emerging markets such as India and China is leading to a rise in health care spending. This has led to an opening up of research avenues in the bio-pharmaceutical sector and an increase in spending on research. Such intense focus on R&D for drug and biosimilars discovery and innovation is likely to augment the modular laboratory automation market in the near future. Modular laboratory automation is helping clinical and pre-clinical studies by developing, optimizing, and streamlining the laboratory workflow. Major pharmaceutical companies are increasingly realizing the value of R&D and are investing in it to maintain a competitive edge. This focus on R&D is likely to propel the modular laboratory automation market during the forecast period. Moreover, the trend of system miniaturization is anticipated to drive the global modular laboratory automation market.
The global modular laboratory automation market can be segmented based on product, application, end-user, and region. In terms of product, the market can be divided into equipment, software, and services. The equipment segment can be further categorized into automated plate handlers, robotic arms, automated liquid handlers, automated storage & retrieval systems (ASRS), and analyzers. Based on application, the global modular laboratory automation market can be classified into clinical diagnostics, genomics, drug discovery and development, proteomics, and others. In terms of end-user, the market can be categorized into hospitals, diagnostic laboratories, pharmaceutical and biotechnology industry, academic and research organizations, and others.
Based on region, the global modular laboratory automation market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America and Europe are projected to be dominant regions of the modular laboratory automation market due to significant adoption of advanced technologies across all end-user segments. Additionally, investments in cutting-edge genomics, proteomics, and epigenetics research; rise in emphasis on remedies for environmental concerns, and concentration of some of the world’s major pharmaceutical and biotechnology organizations and academic institutes in the region are estimated to drive the market. Changing demographics in emerging economies such as China, India, Brazil, and South Africa are expected to present prominent growth opportunities to the modular laboratory automation market. The biopharma industry in Asia Pacific is expected to expand at a significant growth rate during the forecast period as major economies in the region are exploring and enhancing research and development capabilities in several fields in the bioscience domain. The pharmaceutical industry in Asia Pacific is expanding rapidly. This provides prominent platforms for investment for major players to drive sales of modular laboratory automation systems.
Key players in the global modular laboratory automation market include BD and Company, Beckman Coulter, Inc. (Danaher Corporation), Synchron Lab Automation, Siemens Healthineers, Agilent Technologies, and Thermo Fisher Scientific, Inc..
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.